Szarkóma: vizsgálatok itt: Izrael
9 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Haifa, Ramat Gan
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Haifa, Tel Aviv
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - 1/2. fázisTaking peopleA Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- Where
- Jerusalem, Tel Aviv
- People
- 64 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07602777 - No phaseTaking peopleInternational Rare Brain Tumor Registry
- Where
- Haifa, Petah Tikva, Tel Aviv, Tel HaShomer
- Életkor
- Up to 45 év
- People
- 5800 worldwide
- Run by
- Children's National Research Institute
See details and how to joinNCT05697874 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
- Where
- Jerusalem
- Életkor
- 18 év and over
- People
- 56
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT04534127 - No phaseNot yet taking people in IzraelAcupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma
- Where
- Jerusalem
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Shaare Zedek Medical Center
See details and how to joinNCT06500715 - No phaseTaking peopleAlpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
- Where
- Haifa
- Életkor
- 18 év and over
- People
- 30
- Run by
- Alpha Tau Medical LTD.
See details and how to joinNCT03889899 - 1/2. fázisTaking peopleAnti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Where
- Jerusalem
- Életkor
- 18 év to 70 év
- People
- 3
- Run by
- Hadassah Medical Organization
See details and how to joinNCT05296564 - 1/2. fázisTaking peopleFaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Where
- Haifa, Jerusalem, Petah Tikva, Tel Aviv, Tel HaShomer
- People
- 1672 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00